ZA200804665B - Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt - Google Patents

Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

Info

Publication number
ZA200804665B
ZA200804665B ZA200804665A ZA200804665A ZA200804665B ZA 200804665 B ZA200804665 B ZA 200804665B ZA 200804665 A ZA200804665 A ZA 200804665A ZA 200804665 A ZA200804665 A ZA 200804665A ZA 200804665 B ZA200804665 B ZA 200804665B
Authority
ZA
South Africa
Prior art keywords
fluorophenly
pyrrol
dihydroxy
carbonyl
isopropyl
Prior art date
Application number
ZA200804665A
Inventor
Sattigeri Jitendra Anant
Sethi Sachin
Kishore Kaushal
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200804665B publication Critical patent/ZA200804665B/en

Links

ZA200804665A 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt ZA200804665B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2964DE2005 2005-11-08

Publications (1)

Publication Number Publication Date
ZA200804665B true ZA200804665B (en) 2009-07-29

Family

ID=40114304

Family Applications (3)

Application Number Title Priority Date Filing Date
ZA200804665A ZA200804665B (en) 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
ZA200804664A ZA200804664B (en) 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination

Family Applications After (2)

Application Number Title Priority Date Filing Date
ZA200804664A ZA200804664B (en) 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination

Country Status (2)

Country Link
CN (3) CN101304968A (en)
ZA (3) ZA200804665B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102013157B1 (en) * 2015-03-31 2019-08-23 대원제약주식회사 Crystalline form and Method of preparing the same
KR102218320B1 (en) * 2019-07-12 2021-02-23 대원제약주식회사 Method of preparing(3r,5r)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-((4-hydroxymethylphenylamino)carbonyl)-pyrrol-1-yl)-3,5-dihydroxy-heptanoic acid hemi calcium salt, and method of preparing intermediates used therein
CN111494369B (en) * 2020-05-27 2022-07-01 上海市第五人民医院 Compound pharmaceutical composition for coronary heart disease
CN113143916A (en) * 2021-04-28 2021-07-23 苏州大学 Application of Batimastat in preparation of medicine for preventing and treating obesity and secondary bone loss

Also Published As

Publication number Publication date
CN101304967A (en) 2008-11-12
ZA200804666B (en) 2010-01-27
ZA200804664B (en) 2009-04-29
CN101304968A (en) 2008-11-12
CN101304744A (en) 2008-11-12
CN101304967B (en) 2011-10-05

Similar Documents

Publication Publication Date Title
SG166829A1 (en) Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
SMT201400142B (en) N- (1H-indazol-4-yl) immidazo [1,2-A] pyridin-3-carboxamide compounds substituted as cfms inhibitors
IL192241A0 (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
ZA200806066B (en) Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof
HK1115631A1 (en) Process for the identification of novel enzyme interacting compounds
IL189589A0 (en) Method for preparation of pharmaceutical composition having improved disintegratability
WO2007138282A3 (en) Bi-aryl or aryl-heteroaryl substituted indoles
DE602005027388D1 (en) MALONIC ACID AMID DERIVATIVES AS INHIBITORS OF G-SEKRETASE FOR THE TREATMENT OF ALZHEIMER DISEASE
EP2358691B8 (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
IL184885A0 (en) 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension
ZA200804665B (en) Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
DE602006019710D1 (en) MAGNESIUM SALT OF HMG COA REDUCTASE INHIBITORS
WO2005123670A3 (en) Crystalline form of a substituted pyrrolidine compound
AP2007004270A0 (en) Process for preparing salts of hydrocyanic acid
EP1984327A4 (en) An improved process for the preparation of cilastatin and sodium salt
WO2007118873A3 (en) Polymorphs of atorvastatin sodium and magnesium salts
DK2402306T3 (en) Process for Preparation of 5-Aminolaevulinic Acid Hydrochloride
EP1883619A4 (en) Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
PT1829872E (en) Processes for production of indole compounds
SI1891446T1 (en) Process for the identification of novel enzyme interacting compounds
FR2894596B1 (en) PROCESS FOR AUTOCALIBRATION OF BIOPUCES
WO2008010087A3 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
EP1971333A4 (en) Amino acid derivatives of indolinone based protein kinase inhibitors